X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

A new era in Alzheimer’s innovation

By Andrew Powaleny  |    April 19, 2018
After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds...   Read More

New report shows over 500 medicines in development for neurological disorders

By Andrew Powaleny  |    April 18, 2018
Neurological disorders, which include more than 1,000 conditions that disrupt the brain and nervous system, affect an estimated 100 million Americans, nearly one third of the U.S. population....   Read More

Guest post: Advancing healthy hearts for patients

By Guest Contributor  |    February 28, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

New report shows 200 medicines in development for heart disease and stroke

By Andrew Powaleny  |    February 20, 2018
Cardiovascular disease, which includes heart disease and stroke, is the leading cause of death in the United States, accounting for one out of every three deaths. According to the American Heart...   Read More

World AIDS Day 2017: Scientific breakthroughs paving the way for an AIDS-free generation

By Andrew Powaleny  |    December 1, 2017
Today marks World AIDS Day, a moment to reflect on the significant advances made in the treatment and prevention of HIV, the virus which causes AIDS. The incredible scientific progress...   Read More

2017 Research & Hope Awards honor innovators in mental health

By Hannah Mooney  |    October 10, 2017
Mental health disorders are a heavy human and economic burden in the United States. More than 40 million people across the country are impacted by mental illness, and it’s estimated that in any...   Read More

More than 85 medicines in development for Alzheimer’s disease

By Andrew Powaleny  |    September 21, 2017
When Brian Kursonis started “blanking out” for moments at a time, a scan revealed plaques of a protein called amyloid in the brain, one sign of Alzheimer’s disease. A test of his spinal fluid...   Read More

Medicare Monday: Strengthening access to vaccines for seniors

By Nicole Longo  |    August 14, 2017
This month, we’re celebrating National Immunization Awareness Month! Although children may come to mind first when we think of vaccination, access to immunization is just as important for older...   Read More

Finding cures for incurable diseases

By Guest Contributor  |    July 25, 2017
By Sandra Raymond, president and CEO, The Lupus Foundation of America   Read More

New report portrays flourishing pipeline

By Gretta Stone  |    July 18, 2017
It’s an exciting time to be working in the biopharmaceutical industry. Almost every day new headlines highlight remarkable new advances in the fight against disease. Some have called this the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates